BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8158288)

  • 1. Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Kawana T; Fujii A
    J Nihon Univ Sch Dent; 1993 Dec; 35(4):267-75. PubMed ID: 8158288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampicillin concentrations in human oral tissues following a single oral administration of lenampicillin.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Kaneko K; Yamane J; Fujii A; Yamamoto H
    Gen Pharmacol; 1991; 22(5):797-800. PubMed ID: 1761182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin concentrations in radicular cysts following a single oral administration of bacampicillin.
    Akimoto Y; Mochizuki Y; Uda A; Shibutani J; Nishimura H; Komiya M; Kaneko K; Fujii A; Yamamoto H
    Gen Pharmacol; 1993 Jul; 24(4):895-8. PubMed ID: 8224746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Josamycin concentrations in radicular cysts following a single oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Saito S; Kaneko K; Fujii A; Yamamoto H
    Gen Pharmacol; 1993 Jan; 24(1):143-5. PubMed ID: 8482488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of oral lomefloxacin in serum and bronchial mucosa.
    Baldwin DR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1017-9. PubMed ID: 2393260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefadroxil concentrations in human serum, gingiva, and mandibular bone following a single oral administration.
    Akimoto Y; Komiya M; Kaneko K; Fujii A
    J Oral Maxillofac Surg; 1994 Apr; 52(4):397-400; discussion 400-1. PubMed ID: 8133373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
    Leigh DA; Harris C; Tait S; Walsh B; Hancock P
    J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
    Lebrec D; Gaudin C; Benhamou JP
    Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lomefloxacin concentrations in bone after a single oral dose.
    On A; Nightingale CH; Quintiliani R; Sweeney KR; Pasternak HS; Maderazo EG
    Am J Med; 1992 Apr; 92(4A):15S-17S. PubMed ID: 1316064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
    Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalexin concentrations in human serum, gingiva, and mandibular bone following a single oral administration.
    Akimoto Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Fujii A
    Gen Pharmacol; 1990; 21(5):621-3. PubMed ID: 2276582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal clearance of lomefloxacin is decreased by furosemide.
    Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study.
    Cazzola M; Matera MG; Tufano MA; Catalanotti P; Polverino M; Cantoni V; Fici F; Sarlo F; Rossi F
    J Chemother; 2001 Aug; 13(4):407-12. PubMed ID: 11589484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.